These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 21876459
1. Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi. Konstantina A, Lazaris AC, Ioannidis E, Liossi A, Aroni K. Melanoma Res; 2011 Oct; 21(5):389-94. PubMed ID: 21876459 [Abstract] [Full Text] [Related]
2. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, Offidani A. Cancer; 2002 Nov 01; 95(9):1963-70. PubMed ID: 12404291 [Abstract] [Full Text] [Related]
11. Expression of the embryonic morphogen Nodal in cutaneous melanocytic lesions. Yu L, Harms PW, Pouryazdanparast P, Kim DS, Ma L, Fullen DR. Mod Pathol; 2010 Sep 01; 23(9):1209-14. PubMed ID: 20495543 [Abstract] [Full Text] [Related]
12. The role of vascular endothelial growth factors and their receptors in malignant melanomas. Brychtova S, Bezdekova M, Brychta T, Tichy M. Neoplasma; 2008 Sep 01; 55(4):273-9. PubMed ID: 18505336 [Abstract] [Full Text] [Related]
13. TSLC1 expression discriminates cutaneous melanomas from dysplastic nevi. You Y, Wang SH, Zhang JF, Zheng SY. Melanoma Res; 2012 Dec 01; 22(6):430-5. PubMed ID: 23047161 [Abstract] [Full Text] [Related]
14. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS. Chokoeva AA, Ananiev J, Wollina U, Tana C, Lotti T, Cardoso JC, Tchernev G. J Biol Regul Homeost Agents; 2015 Dec 01; 29(3):695-9. PubMed ID: 26403409 [Abstract] [Full Text] [Related]
15. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions. Gambichler T, Rotterdam S, Radkowski K, Altmeyer P, Kreuter A. Am J Clin Pathol; 2009 May 01; 131(5):710-4. PubMed ID: 19369632 [Abstract] [Full Text] [Related]
17. Absence of estrogen receptors in dysplastic nevi and malignant melanoma. Lecavalier MA, From L, Gaid N. J Am Acad Dermatol; 1990 Aug 01; 23(2 Pt 1):242-6. PubMed ID: 2212119 [Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness. Bayer-Garner IB, Hough AJ, Smoller BR. Mod Pathol; 1999 Aug 01; 12(8):770-4. PubMed ID: 10463478 [Abstract] [Full Text] [Related]